In last trading session, AIkido Pharma Inc. (NASDAQ:AIKI) saw 1,570,342 shares changing hands with its beta currently measuring 1.15. Company’s recent per share price level of $0.8461 trading at $0 or 4% at recent trade assigns it a market valuation of $29.62 Million. That current price of AIKI’s stock is at a discount of -223.84% from its 52-week high price of $2.74 and is indicating a premium of 43.27% from its 52-week low price of $0.48. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 9.13 Million shares which gives us an average trading volume of 5.14 Million if we extend that period to 3-months.
For AIkido Pharma Inc. (AIKI), analysts’ consensus is at an average recommendation of 0 while assigning it a mean rating of 0. Splitting up the data highlights that, out of 0 analysts covering the stock, none rated the stock as a Sell while none recommended an Overweight rating for the stock. None suggested the stock as a Hold whereas none see the stock as a Buy. None analyst(s) advised it as an Underweight. The company is expected to be making an EPS of $0 in the current quarter.
AIkido Pharma Inc. (NASDAQ:AIKI) trade information
Upright in the green today for gaining 4.83%, in the last five days AIKI remained trading in the green while hitting it’s week-highest on Monday, Jun 29 when the stock touched $0.898 price level, adding 6.39% to its value on the day. AIkido Pharma Inc.’s shares saw a change of -36.32% in year-to-date performance and have moved -5.73% in past 5-day. AIkido Pharma Inc. (NASDAQ:AIKI) showed a performance of 15.15% in past 30-days. Number of shares sold short was 146.19 Million shares which calculate 28.44 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of $1802.25 to the stock, which implies a rise of 212906.7% to its current value. Analysts have been projecting $1802.25 as a low price target for the stock while placing it at a high target of $1802.25. It follows that stock’s current price would jump +212906.7% in reaching the projected high whereas dropping to the targeted low would mean a loss of 212906.7% for stock’s current value.
AIkido Pharma Inc. (AIKI) estimates and forecasts
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 57.8% during past 5 years. In 2020, company’s earnings growth rate is likely to be around -282.9% while estimates for its earnings growth in next 5 years are of 0%
AIkido Pharma Inc. (NASDAQ:AIKI)’s Major holders
Insiders are in possession of 5.64% of company’s total shares while institution are holding 17.45% percent of that, with stock having share float percentage of 18.5%. Investors also watch the number of corporate investors in a company very closely, which is 13 institutions for AIkido Pharma Inc. that are currently holding shares of the company. Renaissance Technologies, LLC is the top institutional holder at AIKI for having 210.76 Thousand shares of worth $106.83 Thousand. And as of March 30, 2020, it was holding 0.6% of the company’s outstanding shares.
The second largest institutional holder is Two Sigma Securities, LLC, which was holding about 25.69 Thousand shares on March 30, 2020. The number of shares represents firm’s hold over 0.07% of outstanding shares, having a total worth of $13.02 Thousand.